John Hynes
Bristol-Myers Squibb
Discovery of Pyridine Amide Based Inhibitors of Interleukin Receptor-Associated Kinase 4 (IRAK4) for the Treatment of Lupus
David R. Liu
Harvard University
Base editing: Site-selective chemistry on the genome of living cells
Wednesday, May 23, 2018
2:00 PM
